Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
World J Gastroenterol ; 20(10): 2641-52, 2014 Mar 14.
Article in English | MEDLINE | ID: mdl-24627600

ABSTRACT

AIM: To investigate the effects of sodium alginate (AL-Na) on indomethacin-induced small intestinal lesions in rats. METHODS: Gastric injury was assessed by measuring ulcerated legions 4 h after indomethacin (25 mg/kg) administration. Small intestinal injury was assessed by measuring ulcerated legions 24 h after indomethacin (10 mg/kg) administration. AL-Na and rebamipide were orally administered. Myeloperoxidase activity in the stomach and intestine were measured. Microvascular permeability, superoxide dismutase content, glutathione peroxidase activity, catalase activity, red blood cell count, white blood cell count, mucin content and enterobacterial count in the small intestine were measured. RESULTS: AL-Na significantly reduced indomethacin-induced ulcer size and myeloperoxidase activity in the stomach and small intestine. AL-Na prevented increases in microvascular permeability, superoxide dismutase content, glutathione peroxidase activity and catalase activity in small intestinal injury induced by indomethacin. AL-Na also prevented decreases in red blood cells and white blood cells in small intestinal injury induced by indomethacin. Moreover, AL-Na suppressed mucin depletion by indomethacin and inhibited infiltration of enterobacteria into the small intestine. CONCLUSION: These results indicate that AL-Na ameliorates non-steroidal anti-inflammatory drug-induced small intestinal enteritis via bacterial translocation.


Subject(s)
Alginates/pharmacology , Anti-Ulcer Agents/pharmacology , Bacterial Translocation/drug effects , Enteritis/prevention & control , Gastric Mucosa/drug effects , Indomethacin , Intestinal Mucosa/drug effects , Intestine, Small/drug effects , Stomach Ulcer/prevention & control , Anemia/blood , Anemia/chemically induced , Anemia/prevention & control , Animals , Atrophy , Biomarkers/metabolism , Capillary Permeability/drug effects , Catalase/metabolism , Cytoprotection , Disease Models, Animal , Enteritis/blood , Enteritis/chemically induced , Enteritis/microbiology , Enteritis/pathology , Gastric Mucosa/metabolism , Gastric Mucosa/microbiology , Gastric Mucosa/pathology , Glucuronic Acid/pharmacology , Glutathione Peroxidase/metabolism , Hexuronic Acids/pharmacology , Intestinal Mucosa/metabolism , Intestinal Mucosa/microbiology , Intestinal Mucosa/pathology , Intestine, Small/metabolism , Intestine, Small/microbiology , Intestine, Small/pathology , Male , Peroxidase/metabolism , Rats, Sprague-Dawley , Stomach Ulcer/blood , Stomach Ulcer/chemically induced , Stomach Ulcer/microbiology , Stomach Ulcer/pathology , Superoxide Dismutase/metabolism
2.
Biol Pharm Bull ; 36(10): 1528-34, 2013.
Article in English | MEDLINE | ID: mdl-24088251

ABSTRACT

Gastrointestinal mucositis is one of the most prevalent side effects of chemotherapy. Methotrexate is a pro-oxidant compound that depletes dihydrofolate pools and is widely used in the treatment of leukemia and other malignancies. Through its effects on normal tissues with high rates of proliferation, methotrexate treatment leads to gastrointestinal mucositis. In rats, methotrexate-induced gastrointestinal mucositis is histologically characterized by crypt loss, callus fusion and atrophy, capillary dilatation, and infiltration of mixed inflammatory cells. The water-soluble dietary fiber sodium alginate (AL-Na) is derived from seaweed and has demonstrated muco-protective and hemostatic effects on upper gastrointestinal ulcers. In the present study, we evaluated the effects of AL-Na on methotrexate-induced small intestinal mucositis in rats. Animals were subcutaneously administered methotrexate at a dosage of 2.5 mg/kg once daily for 3 d. Rats were treated with single oral doses of AL-Na 30 min before and 6 h after methotrexate administration. On the 4th day, small intestines were removed and weighed. Subsequently, tissues were stained with hematoxylin-eosin and bromodeoxyuridine. AL-Na significantly prevented methotrexate-induced small intestinal mucositis. Moreover, AL-Na prevented decreases in red blood cell numbers, hemoglobin levels, and hematocrit levels. These results suggest the potential of AL-Na as a therapy for methotrexate-induced small intestinal mucositis.


Subject(s)
Alginates/therapeutic use , Antimetabolites, Antineoplastic/adverse effects , Intestinal Mucosa/drug effects , Intestine, Small/drug effects , Methotrexate/adverse effects , Mucositis/prevention & control , Seaweed/chemistry , Alginates/pharmacology , Animals , Dietary Fiber/pharmacology , Dietary Fiber/therapeutic use , Erythrocyte Count , Glucuronic Acid/pharmacology , Glucuronic Acid/therapeutic use , Hematocrit , Hemoglobins/metabolism , Hexuronic Acids/pharmacology , Hexuronic Acids/therapeutic use , Male , Mucositis/chemically induced , Rats , Rats, Sprague-Dawley
3.
Pharmacology ; 92(1-2): 108-16, 2013.
Article in English | MEDLINE | ID: mdl-23989450

ABSTRACT

We evaluated the effects of sodium alginate (AL-Na) on dextran sulfate sodium (DSS)- and 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice. DSS was added to the drinking water for 7 days. In another experiment, DSS was added to the drinking water for 5 days and DSS-free water was provided thereafter. In a separated study, colitis was induced by intrarectally administered TNBS. AL-Na, 5-aminosalicylic acid, or prednisolone was orally administered. These colitis models exhibited colonic damage and produced noticeable inflammatory responses and aggravated goblet cell damage. AL-Na significantly ameliorated DSS- and TNBS-induced experimental colitis and prevented goblet cell damage. Prednisolone also suppressed colitis but caused loss of body and spleen weight. In contrast, AL-Na did not provoke these symptoms. These data suggest that AL-Na may be a possible therapeutic agent for the treatment of inflammatory bowel disease.


Subject(s)
Alginates/therapeutic use , Colitis/drug therapy , Protective Agents/therapeutic use , Alginates/pharmacology , Animals , Colitis/chemically induced , Colitis/metabolism , Colitis/pathology , Colon/metabolism , Colon/pathology , Dextran Sulfate , Disease Models, Animal , Glucuronic Acid/pharmacology , Glucuronic Acid/therapeutic use , Hexuronic Acids/pharmacology , Hexuronic Acids/therapeutic use , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Peroxidase/metabolism , Protective Agents/pharmacology , Serum Amyloid A Protein/metabolism , Trinitrobenzenes
4.
J Pharmacol Sci ; 112(2): 192-202, 2010.
Article in English | MEDLINE | ID: mdl-20093792

ABSTRACT

Recent research has focused on the effects of ambient particulate pollution and much evidence has indicated that particulate pollution is associated with the onset of asthma and allergy; however, the effect of diesel exhaust particles (DEP) on the development of allergen-induced airway remodeling has not been fully investigated in vivo. In the present study, we examined the effects of DEP on Dermatophagoides farinae allergens (Der f)-induced asthma-like phenotypes in mice. Mice were administered i.t. 8 times with Der f. DEP were injected i.t. with Der f 4 times throughout the experiment or twice at the sensitization period. In both cases, DEP aggravated Der f-induced increases in airway responsiveness to acetylcholine, the number of eosinophils and neutrophils in the bronchoalveolar lavage fluid (BALF), serum Der f-specific IgG1 levels, Th2 cytokines and transforming growth factor-beta1 levels in BALF, and amount of hydroxyproline in the right lungs. Furthermore, goblet cell hyperplasia and subepithelial fibrosis were also markedly aggravated. These findings indicate that DEP can potentiate airway remodeling induced by repeated allergen challenge as well as Th2-drived airway hyperresponsiveness, eosinophilic inflammation, and IgG1 production and that DEP can exhibit adjuvant activity for airway remodeling, probably due to the enhancement of allergen sensitization and/or of Th2 polarizing pathways.


Subject(s)
Eosinophilia/etiology , Inflammation/etiology , Pyroglyphidae/immunology , Vehicle Emissions/toxicity , Airway Remodeling/immunology , Animals , Bronchial Hyperreactivity/immunology , Bronchoalveolar Lavage Fluid/immunology , Eosinophilia/immunology , Goblet Cells/metabolism , Hydroxyproline/metabolism , Immunoglobulin G/blood , Inflammation/immunology , Mice , Mice, Inbred BALB C , Th2 Cells/immunology , Transforming Growth Factor beta1/metabolism
5.
Eur J Pharmacol ; 578(1): 87-96, 2008 Jan 06.
Article in English | MEDLINE | ID: mdl-17915213

ABSTRACT

Dermatophagoides farinae are known to be a common environmental allergen causing allergic asthma; however, little is known about their pathophysiological effect via the allergenicities in vivo. Therefore, we first established a mouse model of asthma induced by repeated instillations of D. farinae. Second, to investigate whether the asthmatic responses are Th2-dependent, we examined the effect of the deficiency of interleukin-4 (IL-4) receptor alpha chain gene. Finally, we examined the effect of fluticasone propionate on this model. Mice were instilled with D. farinae without additional adjuvants into the trachea 8 times. After the final allergen instillation, the airway responsiveness to acetylcholine was measured, and bronchoalveolar lavage and histological examination were carried out. The instillation of the allergen-induced airway hyperresponsiveness, the accumulation of inflammatory cells and increases in the levels of Th2 cytokines and transforming growth factor-beta(1) production in the bronchoalveolar lavage fluid dose dependently. The number of goblet cells in the epithelium and the extent of the fibrotic area beneath the basement membrane were also increased in the morphometric study. In contrast, the defect of IL-4/IL-13 signaling through IL-4 receptor alpha chain completely abrogated all these responses. Furthermore, the simultaneous instillation of fluticasone propionate with the allergen showed significant inhibition or an inhibitory tendency of these changes. These findings demonstrate that the repetitive intratracheal instillations of D. farinae can induce airway remodeling through Th2-type inflammation, and that fluticasone propionate inhibits D. farinae-induced airway remodeling in mice, and this model would be useful for studying mechanisms involved in the development of allergic asthma.


Subject(s)
Androstadienes/pharmacology , Anti-Inflammatory Agents/pharmacology , Asthma/drug therapy , Dermatophagoides farinae/immunology , Acetylcholine/pharmacology , Animals , Asthma/immunology , Bronchial Hyperreactivity/immunology , Bronchoalveolar Lavage Fluid/immunology , Disease Models, Animal , Eosinophilia/metabolism , Fluticasone , Goblet Cells/metabolism , Interleukin-4/metabolism , Male , Mice , Mice, Inbred BALB C , Th2 Cells/metabolism , Transforming Growth Factor beta1/biosynthesis
6.
Eur J Pharmacol ; 525(1-3): 128-34, 2005 Nov 21.
Article in English | MEDLINE | ID: mdl-16293242

ABSTRACT

The purpose of this study was to examine prostaglandin E1 (PGE1) transport in rat kidney. [3H]PGE1 administered intravenously was accumulated most abundantly in the renal cortex. Infusion of probenecid and bromcresol green (BCG) decreased [3H]PGE1 accumulation in the renal cortex after injection of [3H]PGE1. To further investigate PGE1 transport in the kidney, [3H]PGE1 uptake by renal cortical slices was examined. Probenecid and BCG inhibited [3H]PGE1 uptake by the slices. Unlabeled PGE1 decreased [3H]PGE1 uptake by renal cortical slices in a concentration-dependent manner. The inhibitory effect of various dicarboxylates with different carbon atoms on [3H]PGE1 uptake was maximal at 6 carbon atoms. Preloading cortical slices with glutarate significantly increased [3H]PGE1 uptake. [3H]PGE1 uptake was inhibited by various eicosanoids and compounds with other structures (p-aminohippurate, benzylpenicillin, estrone-3-sulfate, etc.). These findings suggest that PGE1 uptake by renal cortical slices may be mediated by the members of the organic anion transporter family.


Subject(s)
Alprostadil/metabolism , Kidney Cortex/metabolism , Organic Anion Transporters/metabolism , Animals , Biological Transport , In Vitro Techniques , Kidney Tubules, Proximal/metabolism , Male , Organic Anion Transporters/antagonists & inhibitors , Rats , Rats, Wistar , Tritium
SELECTION OF CITATIONS
SEARCH DETAIL
...